Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pampus

Showing results (221-230 of 250) with videos related to

Pageof 25
Sort By:
BMC Pregnancy and Childbirth|March 20, 2013
Induction of labour with a Foley catheter or oral misoprostol at term: the PROBAAT-II study, a multicentre randomised controlled trialMieke L G Ten Eikelder, Femke Neervoort, Katrien Oude Rengerink, et al.
BMC Pregnancy and Childbirth|September 10, 2009
Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial)Carolien Roos, Liesbeth Hcj Scheepers, Kitty Wm Bloemenkamp, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|June 21, 2014
Prediction of neonatal outcome in women with gestational hypertension or mild preeclampsia after 36 weeks of gestationK van der Tuuk, M A G Holswilder-Olde Scholtenhuis, C M Koopmans, et al.
Lancet (London, England)|October 28, 2011
Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): an open-label, randomised controlled trialMarta Jozwiak, Katrien Oude Rengerink, Marjan Benthem, et al.
BMC Pregnancy and Childbirth|September 3, 2009
Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial)Jolande Y Vis, Femke F Wilms, Martijn A Oudijk, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 13, 2016
An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II)G-J van Baaren, K Broekhuijsen, M G van Pampus, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 7, 2013
Which intrauterine growth restricted fetuses at term benefit from early labour induction? A secondary analysis of the DIGITAT randomised trialParvin Tajik, Linda van Wyk, Kim E Boers, et al.
American Journal of Obstetrics and Gynecology|February 21, 2012
Neonatal morbidity after induction vs expectant monitoring in intrauterine growth restriction at term: a subanalysis of the DIGITAT RCTKim E Boers, Linda van Wyk, Joris A M van der Post, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 28, 2013
Cost-effectiveness of induction of labour at term with a Foley catheter compared to vaginal prostaglandin E₂ gel (PROBAAT trial)G J van Baaren, M Jozwiak, B C Opmeer, et al.
Lancet (London, England)|August 7, 2009
Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trialCorine M Koopmans, Denise Bijlenga, Henk Groen, et al.
Pageof 25

Showing results (221-230 of 250) with videos related to

Sort By:
Pageof 25
BMC Pregnancy and Childbirth|March 20, 2013
Induction of labour with a Foley catheter or oral misoprostol at term: the PROBAAT-II study, a multicentre randomised controlled trialMieke L G Ten Eikelder, Femke Neervoort, Katrien Oude Rengerink, et al.
BMC Pregnancy and Childbirth|September 10, 2009
Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial)Carolien Roos, Liesbeth Hcj Scheepers, Kitty Wm Bloemenkamp, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|June 21, 2014
Prediction of neonatal outcome in women with gestational hypertension or mild preeclampsia after 36 weeks of gestationK van der Tuuk, M A G Holswilder-Olde Scholtenhuis, C M Koopmans, et al.
Lancet (London, England)|October 28, 2011
Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): an open-label, randomised controlled trialMarta Jozwiak, Katrien Oude Rengerink, Marjan Benthem, et al.
BMC Pregnancy and Childbirth|September 3, 2009
Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial)Jolande Y Vis, Femke F Wilms, Martijn A Oudijk, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 13, 2016
An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II)G-J van Baaren, K Broekhuijsen, M G van Pampus, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 7, 2013
Which intrauterine growth restricted fetuses at term benefit from early labour induction? A secondary analysis of the DIGITAT randomised trialParvin Tajik, Linda van Wyk, Kim E Boers, et al.
American Journal of Obstetrics and Gynecology|February 21, 2012
Neonatal morbidity after induction vs expectant monitoring in intrauterine growth restriction at term: a subanalysis of the DIGITAT RCTKim E Boers, Linda van Wyk, Joris A M van der Post, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 28, 2013
Cost-effectiveness of induction of labour at term with a Foley catheter compared to vaginal prostaglandin E₂ gel (PROBAAT trial)G J van Baaren, M Jozwiak, B C Opmeer, et al.
Lancet (London, England)|August 7, 2009
Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trialCorine M Koopmans, Denise Bijlenga, Henk Groen, et al.
Pageof 25